Methodology Protocol

You have free access to this content

Association between personal conflicts of interest and recommendations on medical interventions

  1. Andreas Lundh1,*,
  2. Anders W Jørgensen2,
  3. Lisa Bero3

Editorial Group: Cochrane Methodology Review Group

Published Online: 5 JUN 2013

DOI: 10.1002/14651858.MR000040


How to Cite

Lundh A, Jørgensen AW, Bero L. Association between personal conflicts of interest and recommendations on medical interventions (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: MR000040. DOI: 10.1002/14651858.MR000040.

Author Information

  1. 1

    Rigshospitalet, The Nordic Cochrane Centre, Copenhagen, Denmark

  2. 2

    Aarhus University Hospital, Otorhinolaryngology and Head & Neck Surgery, Aarhus, Denmark

  3. 3

    University of California San Francisco, Department of Clinical Pharmacy and Institute for Health Policy Studies, San Francisco, California, USA

*Andreas Lundh, The Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, 7811, Copenhagen, DK-2100, Denmark. al@cochrane.dk.

Publication History

  1. Publication Status: New
  2. Published Online: 5 JUN 2013

SEARCH

References

Additional references

Bekelman 2003
Bero 1996
  • Bero LA, Rennie D. Influences on the quality of published drug studies. International Journal of Technology Assessment in Health Care 1996;12:209-37.
Bero 2007
  • Bero L, Oostvogel F, Bacchetti P, Lee K. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS Medicine 2007;4:e184.
Brown 2006
  • Brown SD, Daly JC, Kalish LA, McDaniel SA. Financial disclosures of scientific papers presented at the 2003 RSNA Annual Meeting: association with reporting of non-Food and Drug Administration-approved uses of industry products. Radiology 2006;239:849-55.
Choudhry 2002
Chren 1994
  • Chren MM, Landefeld CS. Physicians' behavior and their interactions with drug companies. JAMA 1994;271:684-9.
Horsley 2011
ICMJE 2010
  • International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. Publication ethics: sponsorship, authorship, and accountability. www.icmje.org/urm_full.pdf (accessed 25 March 2013).
Ju 2011
  • Ju BL, Miller CP, Whang PG, Grauer JN. Quantifying the variability of financial disclosure information reported by authors presenting at annual spine conferences. The Spine Journal : Official Journal of the North American Spine Society 2011;11:1-8.
Jørgensen 2007
  • Jørgensen KJ, Klahn A, Gøtzsche PC. Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study. BMC Medicine 2007;5:12.
Krimsky 2006
Lexchin 2003
Lundh 2012
Lurie 2006
  • Lurie P, Almeida CM, Stine N, Stine AR, Wolfe SM. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings. JAMA 2006;295:1921-8.
Murphy 2001
  • Murphy P. Affiliation bias and expert disagreement in framing the nicotine addiction debate. Science, Technology & Human Values 2001;26:278-99.
Okike 2009
  • Okike K, Kocher MS, Wei EX, Mehlman CT, Bhandari M. Accuracy of conflict-of-interest disclosures reported by physicians. New England Journal of Medicine 2009;361:1466-74.
Schott 2010
  • Schott G, Pachl H, Limbach U, Gundert-Remy U, Ludwig WD, Lieb K. The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. Deutsches Arzteblatt International 2010;107:279-85.
Sismondo 2008
Stelfox 1998
Wang 2010
  • Wang AT, McCoy CP, Murad MH, Montori VM. Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. BMJ 2010;340:c1344.